147 related articles for article (PubMed ID: 3696837)
1. Pharmacokinetic profile of cefixime in man.
Faulkner RD; Yacobi A; Barone JS; Kaplan SA; Silber BM
Pediatr Infect Dis J; 1987 Oct; 6(10):963-70. PubMed ID: 3696837
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
[TBL] [Abstract][Full Text] [Related]
3. Absolute bioavailability of cefixime in man.
Faulkner RD; Fernandez P; Lawrence G; Sia LL; Falkowski AJ; Weiss AI; Yacobi A; Silber BM
J Clin Pharmacol; 1988 Aug; 28(8):700-6. PubMed ID: 3216036
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime, in the dog.
Bialer M; Batra VK; Morrison JA; Silber BM; Look ZM; Yacobi A
Pharm Res; 1987 Feb; 4(1):33-7. PubMed ID: 3508527
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic properties of cefixime].
Barré J
Presse Med; 1989 Oct; 18(32):1578-82. PubMed ID: 2530536
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady state.
Faulkner RD; Bohaychuk W; Desjardins RE; Look ZM; Haynes JD; Weiss AI; Silber BM
J Clin Pharmacol; 1987 Oct; 27(10):807-12. PubMed ID: 3429686
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalency of oral suspension formulations of cefixime.
Faulkner RD; Sia LL; Barone JS; Forbes SJ; Silber BM
Biopharm Drug Dispos; 1989; 10(2):205-11. PubMed ID: 2706319
[TBL] [Abstract][Full Text] [Related]
8. Comparative bioavailability study of cefixime administered as tablets or aqueous solution.
Montay G; Masala F; Le Roux Y; Le Liboux A; Uhlrich J; Chassard D; Thebault JJ; Roche G; Frydman A
Drugs; 1991; 42 Suppl 4():6-9. PubMed ID: 1725153
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
Mamzoridi K; Kasteridou N; Peonides A; Niopas I
Pharmacol Toxicol; 1996 Jun; 78(6):417-20. PubMed ID: 8829204
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of cefixime in unweaned calves.
Ziv G; Lavy E; Glickman A; Winkler M
J Vet Pharmacol Ther; 1995 Apr; 18(2):94-100. PubMed ID: 7629935
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacologic aspects of cefixime in dogs.
Lavy E; Ziv G; Aroch I; Glickman A
Am J Vet Res; 1995 May; 56(5):633-8. PubMed ID: 7661460
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of cefixime in the young and elderly.
Faulkner RD; Bohaychuk W; Lanc RA; Haynes JD; Desjardins RE; Yacobi A; Silber BM
J Antimicrob Chemother; 1988 Jun; 21(6):787-94. PubMed ID: 3410802
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic studies on oral antibiotics in pediatrics. I. A pharmacokinetic study on cefixime in pediatrics].
Nakamura H; Iwai N
Jpn J Antibiot; 1991 Sep; 44(9):964-78. PubMed ID: 1960858
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].
Kees F; Naber KG
Infection; 1990; 18 Suppl 3():S150-4. PubMed ID: 2079377
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of cefixime, a new oral cephalosporin.
Nakashima M; Uematsu T; Takiguchi Y; Kanamaru M
J Clin Pharmacol; 1987; 27(5):425-31. PubMed ID: 3693588
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and clinical effects of cefixime in pediatrics].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita S; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Nagayama K
Jpn J Antibiot; 1986 Apr; 39(4):1177-200. PubMed ID: 3761546
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics of cefixime in healthy volunteers after a single oral administration of 200 mg].
Montay G; Le Liboux A; Thebault JJ; Roche G; Frydman A; Gaillot J
Presse Med; 1989 Oct; 18(32):1583-6. PubMed ID: 2530537
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of cefixime in the fasted and fed state.
Faulkner RD; Bohaychuk W; Haynes JD; Desjardins RE; Yacobi A; Silber BM
Eur J Clin Pharmacol; 1988; 34(5):525-8. PubMed ID: 3203716
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of cefixime in patients with impaired renal function].
Maeda H; Sako M; Fujii A; Yamazaki H; Kawabata G; Harada M; Arakawa S; Umezu K; Kamidono S; Ishigami J
Jpn J Antibiot; 1986 Oct; 39(10):2716-20. PubMed ID: 3806957
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetic and bactericidal characteristics of oral cefixime.
Brittain DC; Scully BE; Hirose T; Neu HC
Clin Pharmacol Ther; 1985 Nov; 38(5):590-4. PubMed ID: 4053491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
